Expression of activation markers on decidual and peripheral blood CD4+ T cells, CD8+ T cells, and CD16CD56bright NK cells

Decidua Peripheral blood
% of positive cells (mean ± SD) % of positive cells (mean ± SD)
CD4+ T cells
  IL-2Rα (CD25) 26.9 ± 5.0 20.5 ± 5.2
  IL-2Rβ (CD122) 8.6 ± 4.6 1.5 ± 0.5
  CD69 58.3 ± 12.7 0.9 ± 0.5
  HLA-DR 67.7 ± 14.8 11.8 ± 4.7
CD8+ T cells
  IL-2Rα (CD25) 6.2 ± 2.9 2.5 ± 1.5
  IL-2Rβ (CD122) 17.7 ± 7.2 10.6 ± 3.4
  CD69 73.3 ± 14.3 3.5 ± 0.7
  HLA-DR 82.9 ± 13.5 20.6 ± 7.4
CD16−CD56bright NK cells
  CD69 58.4 ± 11.3 0.07 ± 0.03
  HLA-DR 11.3 ± 4.5 0.7 ± 0.2

SD: standard deviation

Note. Adapted from “Accumulation of CD16CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.” by Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, et al. Int Immunol. 1991;3:743–50 (https://academic.oup.com/intimm/article-lookup/doi/10.1093/intimm/3.8.743). © 1991 Oxford University Press;

“Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2Rα) and IL-2Rβ on T cells of human decidua at an early stage of pregnancy.” by Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M. Immunology. 1992;75:710–2 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1384855). © 1992 Wiley Online Library.